NCT06208904View on ClinicalTrials.gov

The Involvement of the Gut Hormone GIP in the Pathophysiology of Post Prandial Hypotension

NAEnrolling by invitationINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
PostPrandial Hypotension
Interventions
OTHER

Intravenous infusion of GIPRA

Intravenous infusion of GIP(3-30)NH2 in a concentration of 1,000 pmol/kg/min during experimental days

OTHER

Intravenous infusion of saline

Intravenous infusion of isotonic saline 9 mg/ml added 0,5% human serum albumin during experimental days

Trial Locations (1)

2900

Center for Clinical Metabolic Research, Copenhagen

All Listed Sponsors
lead

University Hospital, Gentofte, Copenhagen

OTHER